Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Artificial Neural Network Computer Tomography Perfusion Prediction of Ischemic Core.

Kasasbeh AS, Christensen S, Parsons MW, Campbell B, Albers GW, Lansberg MG.

Stroke. 2019 May 16:STROKEAHA118022649. doi: 10.1161/STROKEAHA.118.022649. [Epub ahead of print]

PMID:
31092162
2.

Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis.

Powers CJ, Dornbos D 3rd, Mlynash M, Gulati D, Torbey M, Nimjee SM, Lansberg MG, Albers GW, Marks MP.

AJNR Am J Neuroradiol. 2019 May 9. doi: 10.3174/ajnr.A6059. [Epub ahead of print]

PMID:
31072970
3.

Collateral blood flow measurement with intravoxel incoherent motion perfusion imaging in hyperacute brain stroke.

Federau C, Wintermark M, Christensen S, Mlynash M, Marcellus DG, Zhu G, Martin BW, Lansberg MG, Albers GW, Heit JJ.

Neurology. 2019 Apr 24. pii: 10.1212/WNL.0000000000007538. doi: 10.1212/WNL.0000000000007538. [Epub ahead of print]

PMID:
31019105
4.

Multimodal magnetic resonance imaging to identify stroke onset within 6 h in patients with large vessel occlusions.

Wouters A, Dupont P, Christensen S, Norrving B, Laage R, Thomalla G, Kemp S, Lansberg M, Thijs V, Albers GW, Lemmens R.

Eur Stroke J. 2018 Jun;3(2):185-192. doi: 10.1177/2396987317753486. Epub 2018 Feb 1.

5.

Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study.

Heit JJ, Mlynash M, Kemp SM, Lansberg MG, Christensen S, Marks MP, Ortega-Gutierrez S, Albers GW.

Stroke. 2019 May;50(5):1172-1177. doi: 10.1161/STROKEAHA.119.024928.

PMID:
30932783
6.

A year-long immune profile of the systemic response in acute stroke survivors.

Tsai AS, Berry K, Beneyto MM, Gaudilliere D, Ganio EA, Culos A, Ghaemi MS, Choisy B, Djebali K, Einhaus JF, Bertrand B, Tanada A, Stanley N, Fallahzadeh R, Baca Q, Quach LN, Osborn E, Drag L, Lansberg MG, Angst MS, Gaudilliere B, Buckwalter MS, Aghaeepour N.

Brain. 2019 Apr 1;142(4):978-991. doi: 10.1093/brain/awz022.

PMID:
30860258
7.

Hypoperfusion Intensity Ratio Is Correlated With Patient Eligibility for Thrombectomy.

Guenego A, Marcellus DG, Martin BW, Christensen S, Albers GW, Lansberg MG, Marks MP, Wintermark M, Heit JJ.

Stroke. 2019 Apr;50(4):917-922. doi: 10.1161/STROKEAHA.118.024134.

PMID:
30841821
8.

Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3.

Christensen S, Mlynash M, Kemp S, Yennu A, Heit JJ, Marks MP, Lansberg MG, Albers GW.

Stroke. 2019 Mar;50(3):754-757. doi: 10.1161/STROKEAHA.118.023392.

PMID:
30735466
9.

Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.

Sarraj A, Mlynash M, Savitz SI, Heit JJ, Lansberg MG, Marks MP, Albers GW.

JAMA Neurol. 2019 Feb 7. doi: 10.1001/jamaneurol.2019.0118. [Epub ahead of print]

PMID:
30734042
10.

DEFUSE 3 Non-DAWN Patients.

Leslie-Mazwi TM, Hamilton S, Mlynash M, Patel AB, Schwamm LH, Lansberg MG, Marks M, Hirsch JA, Albers GW.

Stroke. 2019 Mar;50(3):618-625. doi: 10.1161/STROKEAHA.118.023310.

PMID:
30727856
11.

Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3.

Rao V, Christensen S, Yennu A, Mlynash M, Zaharchuk G, Heit J, Marks MP, Lansberg MG, Albers GW.

Stroke. 2019 Mar;50(3):626-631. doi: 10.1161/STROKEAHA.118.023177.

PMID:
30727840
12.

Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome

de Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, McTaggart RA, Alexander M, Albers G, Broderick J, Marks MP, Heit JJ; DEFUSE 3 Investigators.

Stroke. 2019 Mar;50(3):632-638. doi: 10.1161/STROKEAHA.118.023407.

PMID:
30726184
13.

Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.

Lansberg MG, Mlynash M, Hamilton S, Yeatts SD, Christensen S, Kemp S, Lavori PW, Gutierrez SO, Broderick J, Heit J, Marks MP, Albers GW; DEFUSE 3 Investigators.

JAMA Neurol. 2019 Jan 28. doi: 10.1001/jamaneurol.2018.4587. [Epub ahead of print]

PMID:
30688974
14.

A Relative Noncontrast CT Map to Detect Early Ischemic Changes in Acute Stroke.

Srivatsan A, Christensen S, Lansberg MG.

J Neuroimaging. 2019 Mar;29(2):182-186. doi: 10.1111/jon.12593. Epub 2019 Jan 25.

PMID:
30681223
15.

Response by Demeestere et al to Letter Regarding Article, "Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke".

Demeestere J, Albers GW, Lansberg M, Lemmens R.

Stroke. 2018 Nov 29:STROKEAHA118023955. doi: 10.1161/STROKEAHA.118.023955. [Epub ahead of print] No abstract available.

PMID:
30580744
16.

Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke.

Demeestere J, Scheldeman L, Cornelissen SA, Heye S, Wouters A, Dupont P, Christensen S, Mlynash M, Albers GW, Lansberg M, Lemmens R.

Stroke. 2018 Oct;49(10):2361-2367. doi: 10.1161/STROKEAHA.118.021961.

PMID:
30355098
17.

CT perfusion in acute stroke: Practical guidance for implementation in clinical practice.

Christensen S, Lansberg MG.

J Cereb Blood Flow Metab. 2018 Oct 22:271678X18805590. doi: 10.1177/0271678X18805590. [Epub ahead of print] No abstract available.

PMID:
30346227
18.

Hypoperfusion ratio predicts infarct growth during transfer for thrombectomy.

Guenego A, Mlynash M, Christensen S, Kemp S, Heit JJ, Lansberg MG, Albers GW.

Ann Neurol. 2018 Oct;84(4):616-620. doi: 10.1002/ana.25320. Epub 2018 Sep 23.

PMID:
30168180
19.

Prognostic Value of BEFAST vs. FAST to Identify Stroke in a Prehospital Setting.

Pickham D, Valdez A, Demeestere J, Lemmens R, Diaz L, Hopper S, de la Cuesta K, Rackover F, Miller K, Lansberg MG.

Prehosp Emerg Care. 2019 Mar-Apr;23(2):195-200. doi: 10.1080/10903127.2018.1490837. Epub 2018 Aug 23.

PMID:
30118372
20.

Endovascular Treatment in the DEFUSE 3 Study.

Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, Rasmussen PA, Zaidat OO, Broderick JP, Yeatts SD, Hamilton S, Mlynash M, Albers GW; DEFUSE 3 Investigators.

Stroke. 2018 Aug;49(8):2000-2003. doi: 10.1161/STROKEAHA.118.022147.

PMID:
29986935
21.

Thrombectomy for Stroke with Selection by Perfusion Imaging.

Albers GW, Marks MP, Lansberg MG.

N Engl J Med. 2018 May 10;378(19):1849-1850. doi: 10.1056/NEJMc1803856. No abstract available.

PMID:
29742373
22.

Early Cerebral Vein After Endovascular Ischemic Stroke Treatment Predicts Symptomatic Reperfusion Hemorrhage.

Cartmell SCD, Ball RL, Kaimal R, Telischak NA, Marks MP, Do HM, Dodd RL, Albers GW, Lansberg MG, Heit JJ.

Stroke. 2018 Jul;49(7):1741-1746. doi: 10.1161/STROKEAHA.118.021402. Epub 2018 May 8.

PMID:
29739912
23.

Time From Imaging to Endovascular Reperfusion Predicts Outcome in Acute Stroke.

Tsai JP, Mlynash M, Christensen S, Kemp S, Kim S, Mishra NK, Federau C, Nogueira RG, Jovin TG, Devlin TG, Akhtar N, Yavagal DR, Bammer R, Straka M, Zaharchuk G, Marks MP, Albers GW, Lansberg MG; CRISP Investigators.

Stroke. 2018 Apr;49(4):952-957. doi: 10.1161/STROKEAHA.117.018858. Epub 2018 Mar 16.

24.

Can diffusion- and perfusion-weighted imaging alone accurately triage anterior circulation acute ischemic stroke patients to endovascular therapy?

Wolman DN, Iv M, Wintermark M, Zaharchuk G, Marks MP, Do HM, Dodd RL, Albers GW, Lansberg MG, Heit JJ.

J Neurointerv Surg. 2018 Dec;10(12):1132-1136. doi: 10.1136/neurintsurg-2018-013784. Epub 2018 Mar 19.

PMID:
29555872
25.

Reduced Intravoxel Incoherent Motion Microvascular Perfusion Predicts Delayed Cerebral Ischemia and Vasospasm After Aneurysm Rupture.

Heit JJ, Wintermark M, Martin BW, Zhu G, Marks MP, Zaharchuk G, Dodd RL, Do HM, Steinberg GK, Lansberg MG, Albers GW, Federau C.

Stroke. 2018 Mar;49(3):741-745. doi: 10.1161/STROKEAHA.117.020395. Epub 2018 Feb 9.

PMID:
29439196
26.

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators.

N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.

27.

Visual Aids for Patient, Family, and Physician Decision Making About Endovascular Thrombectomy for Acute Ischemic Stroke.

Tokunboh I, Vales Montero M, Zopelaro Almeida MF, Sharma L, Starkman S, Szeder V, Jahan R, Liebeskind D, Gonzalez N, Demchuk A, Froehler MT, Goyal M, Lansberg MG, Lutsep H, Schwamm L, Saver JL.

Stroke. 2018 Jan;49(1):90-97. doi: 10.1161/STROKEAHA.117.018715. Epub 2017 Dec 8.

PMID:
29222229
28.

Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.

Hacke W, Lyden P, Emberson J, Baigent C, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis SM, Donnan GA, Grotta JC, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Olivot JM, Parsons M, Sandercock PA, Toni D, Toyoda K, Wahlgren N, Wardlaw JM, Whiteley WN, Del Zoppo G, Lees KR; Stroke Thrombolysis Trialists’ Collaborators Group.

Int J Stroke. 2018 Feb;13(2):175-189. doi: 10.1177/1747493017744464. Epub 2017 Nov 24. Erratum in: Int J Stroke. 2018 Feb;13(2):NP3.

PMID:
29171359
29.

A Comparison of Relative Time to Peak and Tmax for Mismatch-Based Patient Selection.

Wouters A, Christensen S, Straka M, Mlynash M, Liggins J, Bammer R, Thijs V, Lemmens R, Albers GW, Lansberg MG.

Front Neurol. 2017 Oct 13;8:539. doi: 10.3389/fneur.2017.00539. eCollection 2017.

30.

A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).

Albers GW, Lansberg MG, Kemp S, Tsai JP, Lavori P, Christensen S, Mlynash M, Kim S, Hamilton S, Yeatts SD, Palesch Y, Bammer R, Broderick J, Marks MP.

Int J Stroke. 2017 Oct;12(8):896-905. doi: 10.1177/1747493017701147. Epub 2017 Mar 24.

31.

Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke.

Lansberg MG, Christensen S, Kemp S, Mlynash M, Mishra N, Federau C, Tsai JP, Kim S, Nogueria RG, Jovin T, Devlin TG, Akhtar N, Yavagal DR, Haussen D, Dehkharghani S, Bammer R, Straka M, Zaharchuk G, Marks MP, Albers GW; CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project (CRISP) Investigators.

Ann Neurol. 2017 Jun;81(6):849-856. doi: 10.1002/ana.24953. Epub 2017 Jun 9.

32.

Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.

Elkins J, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K, Lansberg MG, Tang W, Chang I, Muralidharan K, Gheuens S, Mehta L, Elkind MSV.

Lancet Neurol. 2017 Mar;16(3):217-226. doi: 10.1016/S1474-4422(16)30357-X. Epub 2017 Feb 15.

PMID:
28229893
33.

Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.

Cramer SC, Wolf SL, Adams HP Jr, Chen D, Dromerick AW, Dunning K, Ellerbe C, Grande A, Janis S, Lansberg MG, Lazar RM, Palesch YY, Richards L, Roth E, Savitz SI, Wechsler LR, Wintermark M, Broderick JP.

Stroke. 2017 Mar;48(3):813-819. doi: 10.1161/STROKEAHA.116.015501. Epub 2017 Feb 7. No abstract available.

34.

Prediction of final infarct volume on subacute MRI by quantifying cerebral edema in ischemic stroke.

Tipirneni-Sajja A, Christensen S, Straka M, Inoue M, Lansberg MG, Mlynash M, Bammer R, Parsons MW, Donnan GA, Davis SM, Albers GW.

J Cereb Blood Flow Metab. 2017 Aug;37(8):3077-3084. doi: 10.1177/0271678X16683960. Epub 2016 Jan 1.

35.

Optimal Computed Tomographic Perfusion Scan Duration for Assessment of Acute Stroke Lesion Volumes.

Kasasbeh AS, Christensen S, Straka M, Mishra N, Mlynash M, Bammer R, Albers GW, Lansberg MG.

Stroke. 2016 Dec;47(12):2966-2971. Epub 2016 Nov 15.

36.

Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data.

Lansberg MG, Bhat NS, Yeatts SD, Palesch YY, Broderick JP, Albers GW, Lai TL, Lavori PW.

Stroke. 2016 Dec;47(12):2931-2937. Epub 2016 Nov 15.

37.

Comparison of stroke volume evolution on diffusion-weighted imaging and fluid-attenuated inversion recovery following endovascular thrombectomy.

Federau C, Christensen S, Mlynash M, Tsai J, Kim S, Zaharchuk G, Inoue M, Straka M, Mishra NK, Kemp S, Lansberg MG, Albers GW.

Int J Stroke. 2017 Jul;12(5):510-518. doi: 10.1177/1747493016677985. Epub 2016 Nov 4.

PMID:
27811306
38.

Detection of Atrial Fibrillation Among Patients With Stroke Due to Large or Small Vessel Disease: A Meta-Analysis.

Demeestere J, Fieuws S, Lansberg MG, Lemmens R.

J Am Heart Assoc. 2016 Sep 26;5(9). pii: e004151.

39.

Development of a Mobile Tool That Semiautomatically Screens Patients for Stroke Clinical Trials.

Spokoyny I, Lansberg M, Thiessen R, Kemp SM, Aksoy D, Lee Y, Mlynash M, Hirsch KG.

Stroke. 2016 Oct;47(10):2652-5. doi: 10.1161/STROKEAHA.116.013456. Epub 2016 Sep 8.

40.

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.

Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group.

Stroke. 2016 Sep;47(9):2373-9. doi: 10.1161/STROKEAHA.116.013644. Epub 2016 Aug 9.

41.

Pretreatment blood-brain barrier disruption and post-endovascular intracranial hemorrhage.

Leigh R, Christensen S, Campbell BC, Marks MP, Albers GW, Lansberg MG; DEFUSE 2 Investigators.

Neurology. 2016 Jul 19;87(3):263-9. doi: 10.1212/WNL.0000000000002862. Epub 2016 Jun 17.

42.

Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.

Whiteley WN, Emberson J, Lees KR, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Olivot JM, Parsons M, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Del Zoppo GJ, Sandercock P, Hacke W, Baigent C; Stroke Thrombolysis Trialists' Collaboration.

Lancet Neurol. 2016 Aug;15(9):925-933. doi: 10.1016/S1474-4422(16)30076-X. Epub 2016 Jun 8.

PMID:
27289487
43.

Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities.

Warach SJ, Luby M, Albers GW, Bammer R, Bivard A, Campbell BC, Derdeyn C, Heit JJ, Khatri P, Lansberg MG, Liebeskind DS, Majoie CB, Marks MP, Menon BK, Muir KW, Parsons MW, Vagal A, Yoo AJ, Alexandrov AV, Baron JC, Fiorella DJ, Furlan AJ, Puig J, Schellinger PD, Wintermark M; Stroke Imaging Research (STIR) and VISTA-Imaging Investigators.

Stroke. 2016 May;47(5):1389-98. doi: 10.1161/STROKEAHA.115.012364. Epub 2016 Apr 12.

44.

Blood Pressure Management in Acute Stroke.

Jusufovic M, Mishra NK, Lansberg MG, Bath PM, Berge E, Sandset EC.

Curr Hypertens Rev. 2016;12(2):121-6. Review.

PMID:
26931471
45.

Effect of endovascular reperfusion in relation to site of arterial occlusion.

Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, Albers GW, Lansberg MG; DEFUSE 2, IMS III, STAR, and SWIFT trialists; DEFUSE 2 IMS III STAR and SWIFT trialists.

Neurology. 2016 Feb 23;86(8):762-70. doi: 10.1212/WNL.0000000000002399. Epub 2016 Jan 22.

46.

Identification of imaging selection patterns in acute ischemic stroke patients and the influence on treatment and clinical trial enrollment decision making.

Luby M, Warach SJ, Albers GW, Baron JC, Cognard C, Dávalos A, Donnan GA, Fiebach JB, Fiehler J, Hacke W, Lansberg MG, Liebeskind DS, Mattle HP, Oppenheim C, Schellinger PD, Wardlaw JM, Wintermark M.

Int J Stroke. 2016 Feb;11(2):180-90. doi: 10.1177/1747493015616634.

47.

Magnetic resonance imaging-based endovascular versus medical stroke treatment for symptom onset up to 12 h.

Wouters A, Lemmens R, Christensen S, Wilms G, Dupont P, Mlynash M, Schneider A, Laage R, Cereda CW, Lansberg MG, Albers GW, Thijs V; AXIS 2 and DEFUSE 2 study investigators.

Int J Stroke. 2016 Jan;11(1):127-33. doi: 10.1177/1747493015607503.

PMID:
26763028
48.

Inter-rater agreement analysis of the Precise Diagnostic Score for suspected transient ischemic attack.

Cereda CW, George PM, Inoue M, Vora N, Olivot JM, Schwartz N, Lansberg MG, Kemp S, Mlynash M, Albers GW.

Int J Stroke. 2016 Jan;11(1):85-92. doi: 10.1177/1747493015607507. Erratum in: Int J Stroke. 2016 Apr;11(3):NP42-3.

PMID:
26763024
49.

Evolution of Volume and Signal Intensity on Fluid-attenuated Inversion Recovery MR Images after Endovascular Stroke Therapy.

Federau C, Mlynash M, Christensen S, Zaharchuk G, Cha B, Lansberg MG, Wintermark M, Albers GW.

Radiology. 2016 Jul;280(1):184-92. doi: 10.1148/radiol.2015151586. Epub 2016 Jan 13.

PMID:
26761721
50.

A benchmarking tool to evaluate computer tomography perfusion infarct core predictions against a DWI standard.

Cereda CW, Christensen S, Campbell BCV, Mishra NK, Mlynash M, Levi C, Straka M, Wintermark M, Bammer R, Albers GW, Parsons MW, Lansberg MG.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1780-1789. Epub 2015 Oct 19.

Supplemental Content

Loading ...
Support Center